|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2011-1-17
|
|
pubmed:abstractText |
Despite the given advances in neuro-oncology most patients with high grade malignant glioma ultimately fail locally or locoregionally. In parallel with improvements of initial treatment options, several salvage strategies have been elucidated and already entered clinical practice. Aim of this article is to review the current status of salvage strategies in recurrent high grade glioma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1879-0887
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
98
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1-14
|
|
pubmed:meshHeading |
pubmed-meshheading:21159396-Angiogenesis Inhibitors,
pubmed-meshheading:21159396-Brachytherapy,
pubmed-meshheading:21159396-Brain Neoplasms,
pubmed-meshheading:21159396-Glioma,
pubmed-meshheading:21159396-Humans,
pubmed-meshheading:21159396-Neoplasm Recurrence, Local,
pubmed-meshheading:21159396-Radiosurgery,
pubmed-meshheading:21159396-Radiotherapy Dosage,
pubmed-meshheading:21159396-Receptor, Epidermal Growth Factor,
pubmed-meshheading:21159396-Receptors, Vascular Endothelial Growth Factor,
pubmed-meshheading:21159396-Salvage Therapy
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Therapeutic options for recurrent malignant glioma.
|
|
pubmed:affiliation |
Department of Radiation Oncology, Ludwig-Maximilians-University Munich, München, Germany.
|
|
pubmed:publicationType |
Journal Article,
Review
|
